Janssen Research & Development, Llc
Clinical trials sponsored by Janssen Research & Development, Llc, explained in plain language.
-
Halted trial tests new drug to keep depression at bay
Disease control TerminatedThis study tested whether adding a new drug called aticaprant to standard antidepressants could help prevent depression from coming back in people who had recently gotten better. It focused on people whose depression includes a severe loss of interest and pleasure in life. The tr…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug aims to restore joy for those whose depression resists treatment
Symptom relief TerminatedThis study tested whether adding an experimental drug called aticaprant to a person's current antidepressant could better treat major depression, specifically for people who struggle with severe anhedonia—the inability to feel pleasure. It involved 101 adults whose depression had…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC